(Total Views: 79)
Posted On: 12/03/2019 3:25:43 PM
Post# of 74565
$RFL News Article - Timothy Pardee, M.D., Ph.D., Co-Chief Medical Officer of Rafael Pharmaceuticals, to Present on CPI-613 (devimistat) in Relapsed/Refractory Acute Myeloid Leukemia (AML) at the 2019 American Society of Hematology (ASH) Annual Meeting & Expos https://marketwirenews.com/news-releases/timo...48709.html
(0)
(0)
My Twitter: WhyteStocks
